Bruker Stock Earnings Reports

Bruker reported Q1 FY2026 revenue of $823.4M (+2.7% reported) that reflected an organic revenue decline of 4.4% but was aided by 4.5% FX tailwind and 2.6% from acquisitions. Bookings were a clear bright spot: BSI organic bookings grew high-single-digits and the BSI book-to-bill was >1.0x for a third consecutive quarter. Segment highlights: Semi Metrology (now >$300M annual revenue) and AI-driven businesses (Semi Metrology, SciY lab digitization/software) saw strong order growth (>20% in select pockets); Security Detection is expanding (~$70M expected revenue this year); BEST saw large multi-year superconductor and Fusion/R&I orders (including ~$600M of multi-year superconductor orders Dec–Apr). Gross margin (non-GAAP) was 50.0% and operating margin 10.2% (both down YoY, impacted by FX, tariffs and mix) but both beat expectations. Non-GAAP EPS was $0.31. Management is executing aggressive cost actions: annualized savings now tracking ~ $140M (above prior $100–120M target), with most savings expected to appear in Q2 and later quarters and ramp into FY2027. Cash flow: operating cash flow $71M and free cash flow $47M; net leverage fell to ~2.9x after $180M debt paydown. Management reconfirmed FY2026 guidance: reported revenue $3.57–3.60B, organic revenue growth 1–2%, non-GAAP operating margin expansion of ~250–300 bps (after FX headwinds), and non-GAAP EPS $2.10–2.15 (implying 15–17% growth; CER EPS growth ~23–25%). Near term outlook: Q2 organic revenue expected low- to mid-single-digit growth; management expects meaningful sequential margin and EPS improvement beginning in Q2 and continuing through H2. Key investor takeaways: improving order momentum (especially outside the U.S. and in AI/semiconductor-driven niches), significant cost savings to drive margin expansion, reconfirmed full-year guidance despite macro/FX headwinds, and continued deleveraging.